Abramson Cancer Center at the University of Pennsylvania — Phildelphia, Pennsylvania

Abramson Cancer Center at the University of Pennsylvania is a clinical research site located in Phildelphia, Pennsylvania, United States 19104.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Abramson Cancer Center at the University of Pennsylvania has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Pancreatic Cancer, Adult.

Sponsors: Geistlich Pharma AG.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Abramson Cancer Center at the University of Pennsylvania?

Abramson Cancer Center at the University of Pennsylvania has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Abramson Cancer Center at the University of Pennsylvania conducted?

Abramson Cancer Center at the University of Pennsylvania has 1 clinical trials on record, with 1 currently active. Their work covers Pancreatic Cancer, Adult.

Is Abramson Cancer Center at the University of Pennsylvania accredited by Crixeo Health?

Abramson Cancer Center at the University of Pennsylvania has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Abramson Cancer Center at the University of Pennsylvania?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.